Topiramate Tablet, Film Coated
Product Images NDC 71335-1147

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-1147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 01)

FDA Label Image

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 02)

Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 02)
This is a chart that shows the cumulative rates for time to first seizure for two groups of individuals taking different doses of topiramate (50 mg/day and 400 mg/day). The chart displays the time in days (ranging from 0 to 400) on the x-axis and the cumulative rate on the y-axis. The chart indicates that the group taking the higher dose of topiramate had a significantly lower cumulative rate for time to first seizure, as represented by the steeper slope for the 400 mg/day line compared to the 50 mg/day line. The p-value for the difference between the two groups is 0.0002.*
FDA Label Image

Topiramate Tablets Usp (39703b05 F774 4aed 9792 000a61531553 03)

Topiramate Tablets Usp (39703b05 F774 4aed 9792 000a61531553 03)
The text provides data on the change from baseline to double-blind phase in the average monthly migraine period rate of participants treated with different doses of Topiramate and placebo. The table shows the number of participants in each treatment group (indicated by dosage) and reports the significance level (*p<0.010.* p<0.001) of the results.*
FDA Label Image

Label (Lbl713351147)

Label (Lbl713351147)
This is information about a medication called Topiramate. It is a round, white to off-white tablet with the imprint "OD15" and has a strength of 50mg. The medication is supposed to be stored at room temperature between 20°-25°C (68°-77°F). It is produced by Cadila Healthcare Ltd. and is compared to Topamax 50mg Tab. The given package contains 30 tablets with an expiration date that is not available. The other text appears to be a reference to a purchase or delivery of the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.